QDEL

SEC source: 0000899243-22-020498 · doc4.xml · derivative · entry 9

WIDDER KENNETH J · CIK 0001065168 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 98

Underlying: Common Stock · 98 shares

Expires not disclosed

F4 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock.

F5 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F6 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule.

F6 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule.

SEC source: 0000899243-22-020498 · doc4.xml · derivative · entry 8

WIDDER KENNETH J · CIK 0001065168 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 328

Underlying: Common Stock · 328 shares

Expires not disclosed

F4 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock.

F5 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F6 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule.

F6 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule.

SEC source: 0000899243-22-020498 · doc4.xml · derivative · entry 7

WIDDER KENNETH J · CIK 0001065168 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 315

Underlying: Common Stock · 315 shares

Expires not disclosed

F4 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock.

F5 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F6 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule.

F6 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule.

SEC source: 0000899243-22-020498 · doc4.xml · derivative · entry 6

WIDDER KENNETH J · CIK 0001065168 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,050

Underlying: Common Stock · 1,050 shares

Expires not disclosed

F4 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock.

F5 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F6 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule.

F6 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule.

SEC source: 0000899243-22-020498 · doc4.xml · derivative · entry 5

WIDDER KENNETH J · CIK 0001065168 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,065

Underlying: Common Stock · 5,065 shares

Expires 2027-05-16

F2 · kind: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options were converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F3 · derivative.exercise_date: Vested in full.

SEC source: 0000899243-22-020498 · doc4.xml · derivative · entry 4

WIDDER KENNETH J · CIK 0001065168 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,021

Underlying: Common Stock · 7,021 shares

Expires 2026-05-17

F2 · kind: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options were converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F3 · derivative.exercise_date: Vested in full.

SEC source: 0000899243-22-020498 · doc4.xml · derivative · entry 3

WIDDER KENNETH J · CIK 0001065168 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,021

Underlying: Common Stock · 7,021 shares

Expires 2025-05-05

F2 · kind: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options were converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F3 · derivative.exercise_date: Vested in full.

SEC source: 0000899243-22-020498 · doc4.xml · derivative · entry 2

WIDDER KENNETH J · CIK 0001065168 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,333

Underlying: Common Stock · 3,333 shares

Expires 2024-11-17

F2 · kind: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options were converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F3 · derivative.exercise_date: Vested in full.

SEC source: 0000899243-22-020498 · doc4.xml · nonDerivative · entry 1

WIDDER KENNETH J · CIK 0001065168 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,684

F1 · kind: Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the "Business Combination Agreement") by and among Quidel Corporation ("Quidel"), Ortho Clinical Diagnostics Holdings plc, QuidelOrtho Corporation ("QuidelOrtho"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each share of common stock of Quidel beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement was exchanged for one share of common stock of QuidelOrtho.

F1 · price: Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the "Business Combination Agreement") by and among Quidel Corporation ("Quidel"), Ortho Clinical Diagnostics Holdings plc, QuidelOrtho Corporation ("QuidelOrtho"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each share of common stock of Quidel beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement was exchanged for one share of common stock of QuidelOrtho.

SEC source: 0000899243-22-020478 · doc4.xml · derivative · entry 2

Smith Christopher M · CIK 0001436707 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 207,984

Underlying: Common Stock · 207,984 shares

Expires 2029-12-20

F3 · kind: Pursuant to the Business Combination Agreement, each Ortho stock option was converted into an equal number of Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions), except as adjusted by the Business Combination Agreement.

F4 · derivative.exercise_date: Vested in full.

SEC source: 0000899243-22-020478 · doc4.xml · nonDerivative · entry 1

Smith Christopher M · CIK 0001436707 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,554

F1 · kind: Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the "Business Combination Agreement") by and among Quidel Corporation, Ortho Clinical Diagnostics Holdings plc ("Ortho"), QuidelOrtho Corporation ("QuidelOrtho"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each ordinary share of Ortho beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement was exchanged for (i) 0.1055 shares of common stock of QuidelOrtho and (ii) $7.14 in cash.

F1 · price: Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the "Business Combination Agreement") by and among Quidel Corporation, Ortho Clinical Diagnostics Holdings plc ("Ortho"), QuidelOrtho Corporation ("QuidelOrtho"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each ordinary share of Ortho beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement was exchanged for (i) 0.1055 shares of common stock of QuidelOrtho and (ii) $7.14 in cash.

F2 · balance_after: Includes 29,418 restricted stock awards, of which 2,101 shares will vest on July 28, 2022, 8,404 shares will vest on September 9, 2022, 2,100 shares will vest on February 28, 2023 and 8,406 shares will vest on May 27, 2023.

SEC source: 0000899243-22-020508 · doc4.xml · derivative · entry 20

BRYANT DOUGLAS C · CIK 0001406652 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 794

Underlying: Common Stock · 794 shares

Expires not disclosed

F10 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock.

F11 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F13 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule.

F19 · derivative.exercise_date: 794 shares will vest on January 31, 2023.

F13 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule.

F19 · derivative.expiration_date: 794 shares will vest on January 31, 2023.

SEC source: 0000899243-22-020508 · doc4.xml · derivative · entry 19

BRYANT DOUGLAS C · CIK 0001406652 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,646

Underlying: Common Stock · 2,646 shares

Expires not disclosed

F10 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock.

F11 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F13 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule.

F13 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule.

SEC source: 0000899243-22-020508 · doc4.xml · derivative · entry 18

BRYANT DOUGLAS C · CIK 0001406652 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,187

Underlying: Common Stock · 24,187 shares

Expires not disclosed

F10 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock.

F11 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F18 · derivative.exercise_date: 12,093 shares will vest on January 31, 2024; the remaining 12,094 shares will vest in equal installments on January 31, 2025 and January 31, 2026.

F18 · derivative.expiration_date: 12,093 shares will vest on January 31, 2024; the remaining 12,094 shares will vest in equal installments on January 31, 2025 and January 31, 2026.

SEC source: 0000899243-22-020508 · doc4.xml · derivative · entry 17

BRYANT DOUGLAS C · CIK 0001406652 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,043

Underlying: Common Stock · 27,043 shares

Expires not disclosed

F10 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock.

F11 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F17 · derivative.exercise_date: 6,760 shares will vest on January 31, 2023; the remaining 20,283 shares will vest in equal installments on January 31, 2024, January 31, 2025 and January 31, 2026.

F17 · derivative.expiration_date: 6,760 shares will vest on January 31, 2023; the remaining 20,283 shares will vest in equal installments on January 31, 2024, January 31, 2025 and January 31, 2026.

SEC source: 0000899243-22-020508 · doc4.xml · derivative · entry 16

BRYANT DOUGLAS C · CIK 0001406652 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,347

Underlying: Common Stock · 3,347 shares

Expires not disclosed

F10 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock.

F11 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F16 · derivative.exercise_date: 1,115 shares will vest on February 1, 2023; the remaining 2,232 shares will vest in equal installments on February 1, 2024 and February 1, 2025.

F16 · derivative.expiration_date: 1,115 shares will vest on February 1, 2023; the remaining 2,232 shares will vest in equal installments on February 1, 2024 and February 1, 2025.

SEC source: 0000899243-22-020508 · doc4.xml · derivative · entry 15

BRYANT DOUGLAS C · CIK 0001406652 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,921

Underlying: Common Stock · 2,921 shares

Expires not disclosed

F10 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock.

F11 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F15 · derivative.exercise_date: 1,460 shares will vest on August 24, 2022 and 1,461 shares will vest on August 24, 2023.

F15 · derivative.expiration_date: 1,460 shares will vest on August 24, 2022 and 1,461 shares will vest on August 24, 2023.

SEC source: 0000899243-22-020508 · doc4.xml · derivative · entry 14

BRYANT DOUGLAS C · CIK 0001406652 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,590

Underlying: Common Stock · 7,590 shares

Expires not disclosed

F10 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock.

F11 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F14 · derivative.exercise_date: 7,590 shares will vest in equal installments on February 3, 2023 and February 3, 2024.

F14 · derivative.expiration_date: 7,590 shares will vest in equal installments on February 3, 2023 and February 3, 2024.

SEC source: 0000899243-22-020508 · doc4.xml · derivative · entry 13

BRYANT DOUGLAS C · CIK 0001406652 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,192

Underlying: Common Stock · 2,192 shares

Expires not disclosed

F10 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock.

F11 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F13 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule.

F13 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule.

SEC source: 0000899243-22-020508 · doc4.xml · derivative · entry 12

BRYANT DOUGLAS C · CIK 0001406652 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,309

Underlying: Common Stock · 7,309 shares

Expires not disclosed

F10 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock.

F11 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F13 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule.

F13 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule.

SEC source: 0000899243-22-020508 · doc4.xml · derivative · entry 11

BRYANT DOUGLAS C · CIK 0001406652 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,720

Underlying: Common Stock · 18,720 shares

Expires not disclosed

F10 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock.

F11 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F12 · derivative.exercise_date: 18,720 shares will vest on February 4, 2023.

F12 · derivative.expiration_date: 18,720 shares will vest on February 4, 2023.

SEC source: 0000899243-22-020508 · doc4.xml · derivative · entry 10

BRYANT DOUGLAS C · CIK 0001406652 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,043

Underlying: Common Stock · 27,043 shares

Expires 2032-01-31

F2 · kind: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options were converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F9 · derivative.exercise_date: 6,760 shares will vest on January 31, 2023; the remaining 20,283 shares will vest in equal installments on January 31, 2024, January 31, 2025 and January 31, 2026.

SEC source: 0000899243-22-020508 · doc4.xml · derivative · entry 9

BRYANT DOUGLAS C · CIK 0001406652 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,140

Underlying: Common Stock · 11,140 shares

Expires 2031-07-28

F2 · kind: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options were converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F8 · derivative.exercise_date: 3,713 shares will vest on July 28, 2022; 3,713 shares will vest on July 28, 2023; and 3,714 shares will vest on July 28, 2024.

SEC source: 0000899243-22-020508 · doc4.xml · derivative · entry 8

BRYANT DOUGLAS C · CIK 0001406652 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,924

Underlying: Common Stock · 8,924 shares

Expires 2031-02-01

F2 · kind: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options were converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F7 · derivative.exercise_date: 2,231 shares are vested in full; the remaining 6,693 shares will vest in equal installments on February 1, 2023, February 1, 2024 and February 1, 2025.

SEC source: 0000899243-22-020508 · doc4.xml · derivative · entry 7

BRYANT DOUGLAS C · CIK 0001406652 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,593

Underlying: Common Stock · 10,593 shares

Expires 2030-08-24

F2 · kind: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options were converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F6 · derivative.exercise_date: 3,531 shares are vested in full; the remaining 7,062 shares will vest in equal installments on August 24, 2022 and August 24, 2023.

SEC source: 0000899243-22-020508 · doc4.xml · derivative · entry 6

BRYANT DOUGLAS C · CIK 0001406652 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,358

Underlying: Common Stock · 30,358 shares

Expires 2030-02-03

F2 · kind: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options were converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F5 · derivative.exercise_date: 15,180 shares are vested in full; the remaining 15,178 shares will vest in equal installments on February 3, 2023 and February 3, 2024.

SEC source: 0000899243-22-020508 · doc4.xml · derivative · entry 5

BRYANT DOUGLAS C · CIK 0001406652 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,440

Underlying: Common Stock · 37,440 shares

Expires 2029-02-04

F2 · kind: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options were converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F4 · derivative.exercise_date: 28,080 shares are vested in full; 9,360 shares will vest on February 4, 2023.

SEC source: 0000899243-22-020508 · doc4.xml · derivative · entry 4

BRYANT DOUGLAS C · CIK 0001406652 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,637

Underlying: Common Stock · 27,637 shares

Expires 2028-01-16

F2 · kind: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options were converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F3 · derivative.exercise_date: Vested in full.

SEC source: 0000899243-22-020508 · doc4.xml · derivative · entry 3

BRYANT DOUGLAS C · CIK 0001406652 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,249

Underlying: Common Stock · 20,249 shares

Expires 2027-02-15

F2 · kind: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options were converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F3 · derivative.exercise_date: Vested in full.

SEC source: 0000899243-22-020508 · doc4.xml · derivative · entry 2

BRYANT DOUGLAS C · CIK 0001406652 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,461

Underlying: Common Stock · 23,461 shares

Expires 2026-02-10

F2 · kind: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options were converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F3 · derivative.exercise_date: Vested in full.

SEC source: 0000899243-22-020508 · doc4.xml · nonDerivative · entry 1

BRYANT DOUGLAS C · CIK 0001406652 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 505,926

F1 · kind: Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the "Business Combination Agreement") by and among Quidel Corporation ("Quidel"), Ortho Clinical Diagnostics Holdings plc, QuidelOrtho Corporation ("QuidelOrtho"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each share of common stock of Quidel beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement was exchanged for one share of common stock of QuidelOrtho.

F1 · price: Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the "Business Combination Agreement") by and among Quidel Corporation ("Quidel"), Ortho Clinical Diagnostics Holdings plc, QuidelOrtho Corporation ("QuidelOrtho"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each share of common stock of Quidel beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement was exchanged for one share of common stock of QuidelOrtho.

SEC source: 0000899243-22-020505 · doc4.xml · derivative · entry 16

BUECHLER KENNETH F · CIK 0001238916 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 236

Underlying: Common Stock · 236 shares

Expires not disclosed

F4 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock.

F5 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F6 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule.

F6 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule.

SEC source: 0000899243-22-020505 · doc4.xml · derivative · entry 15

BUECHLER KENNETH F · CIK 0001238916 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 789

Underlying: Common Stock · 789 shares

Expires not disclosed

F4 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock.

F5 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F6 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule.

F6 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule.

SEC source: 0000899243-22-020505 · doc4.xml · derivative · entry 14

BUECHLER KENNETH F · CIK 0001238916 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 151

Underlying: Common Stock · 151 shares

Expires not disclosed

F4 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock.

F5 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F6 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule.

F6 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule.

SEC source: 0000899243-22-020505 · doc4.xml · derivative · entry 13

BUECHLER KENNETH F · CIK 0001238916 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 506

Underlying: Common Stock · 506 shares

Expires not disclosed

F4 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock.

F5 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F6 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule.

F6 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule.

SEC source: 0000899243-22-020505 · doc4.xml · derivative · entry 12

BUECHLER KENNETH F · CIK 0001238916 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 485

Underlying: Common Stock · 485 shares

Expires not disclosed

F4 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock.

F5 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F6 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule.

F6 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule.

SEC source: 0000899243-22-020505 · doc4.xml · derivative · entry 11

BUECHLER KENNETH F · CIK 0001238916 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,617

Underlying: Common Stock · 1,617 shares

Expires not disclosed

F4 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock.

F5 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F6 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule.

F6 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule.

SEC source: 0000899243-22-020505 · doc4.xml · derivative · entry 10

BUECHLER KENNETH F · CIK 0001238916 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,839

Underlying: Common Stock · 2,839 shares

Expires not disclosed

F4 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock.

F5 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F6 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule.

F6 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule.

SEC source: 0000899243-22-020505 · doc4.xml · derivative · entry 9

BUECHLER KENNETH F · CIK 0001238916 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,145

Underlying: Common Stock · 3,145 shares

Expires not disclosed

F4 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock.

F5 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F6 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule.

F6 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule.

SEC source: 0000899243-22-020505 · doc4.xml · derivative · entry 8

BUECHLER KENNETH F · CIK 0001238916 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,436

Underlying: Common Stock · 2,436 shares

Expires not disclosed

F4 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock.

F5 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F6 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule.

F6 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule.

SEC source: 0000899243-22-020505 · doc4.xml · derivative · entry 7

BUECHLER KENNETH F · CIK 0001238916 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,851

Underlying: Common Stock · 5,851 shares

Expires 2027-05-16

F2 · kind: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options were converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F3 · derivative.exercise_date: Vested in full.

SEC source: 0000899243-22-020505 · doc4.xml · derivative · entry 6

BUECHLER KENNETH F · CIK 0001238916 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,215

Underlying: Common Stock · 9,215 shares

Expires 2026-05-17

F2 · kind: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options were converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F3 · derivative.exercise_date: Vested in full.

SEC source: 0000899243-22-020505 · doc4.xml · derivative · entry 5

BUECHLER KENNETH F · CIK 0001238916 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,811

Underlying: Common Stock · 1,811 shares

Expires 2025-08-17

F2 · kind: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options were converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F3 · derivative.exercise_date: Vested in full.

SEC source: 0000899243-22-020505 · doc4.xml · derivative · entry 4

BUECHLER KENNETH F · CIK 0001238916 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,021

Underlying: Common Stock · 7,021 shares

Expires 2025-05-05

F2 · kind: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options were converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F3 · derivative.exercise_date: Vested in full.

SEC source: 0000899243-22-020505 · doc4.xml · derivative · entry 3

BUECHLER KENNETH F · CIK 0001238916 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,041

Underlying: Common Stock · 9,041 shares

Expires 2024-05-06

F2 · kind: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options were converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F3 · derivative.exercise_date: Vested in full.

SEC source: 0000899243-22-020505 · doc4.xml · derivative · entry 2

BUECHLER KENNETH F · CIK 0001238916 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,081

Underlying: Common Stock · 8,081 shares

Expires 2023-05-14

F2 · kind: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options were converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F3 · derivative.exercise_date: Vested in full.

SEC source: 0000899243-22-020505 · doc4.xml · nonDerivative · entry 1

BUECHLER KENNETH F · CIK 0001238916 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,288

F1 · kind: Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the "Business Combination Agreement") by and among Quidel Corporation ("Quidel"), Ortho Clinical Diagnostics Holdings plc, QuidelOrtho Corporation ("QuidelOrtho"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each share of common stock of Quidel beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement was exchanged for one share of common stock of QuidelOrtho.

F1 · price: Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the "Business Combination Agreement") by and among Quidel Corporation ("Quidel"), Ortho Clinical Diagnostics Holdings plc, QuidelOrtho Corporation ("QuidelOrtho"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each share of common stock of Quidel beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement was exchanged for one share of common stock of QuidelOrtho.

SEC source: 0000899243-22-020500 · doc4.xml · derivative · entry 11

POLAN MARY LAKE PH D · CIK 0001187716 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 128

Underlying: Common Stock · 128 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock.

F3 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F4 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule.

F4 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule.

SEC source: 0000899243-22-020500 · doc4.xml · derivative · entry 10

POLAN MARY LAKE PH D · CIK 0001187716 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 427

Underlying: Common Stock · 427 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock.

F3 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F4 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule.

F4 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule.

SEC source: 0000899243-22-020500 · doc4.xml · derivative · entry 9

POLAN MARY LAKE PH D · CIK 0001187716 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 82

Underlying: Common Stock · 82 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock.

F3 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F4 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule.

F4 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule.